Author Guidelines
The «Farmateka» journal publishes literature reviews, clinical guidelines, information on new drugs and treatment approaches, practical notes, and original research on the clinical use of various drugs and therapies.
Articles and other materials should be sent to the editorial office by e-mail: pharmateca@yandex.ru.
Also, articles be can sent to the address: «Farmateka» journal, "Bionika Media" Ltd Publishing House, 30/1 Obrucheva str., Build. 2, Moscow, 117485
Articles printed in standard font 14 with 1.5 line-spacing are accepted to examination; figures should be provided separately. The article should contain the official referral of the institution in which the work was carried out. Visa and the signature of the research supervisor, certified by the round seal of the institution should be on the first page of article; on the last page - the signatures of all authors, confirming the right of publication of the article in a journal and posting on the publisher’s website. In addition, copies of authorship certificates, certificates for innovation proposal or grant of release are required if these documents are mentioned in the text of the article.
All previously scanned supporting documents must be sent by e-mail to the address: pharmateca@yandex.ru, or to the postal address of the editorial board (see above).
The article should include:
- article title;
- names and initials of the authors (in two languages), ORCID / Scopus ID of all authors;
- the full name of the institution and division (department, laboratory) in which the work was performed (in two languages);
- information about the corresponding author: full name, academic degree, position, place of work (including the postal address of the institution), contacts (e-mail, phone), ORCID / Scopus ID, contacts (e-mail, phone);
- abstract and key words (in Russian and in English).
- figures and tables (at the discretion of the author).
- reference list.
At the end of the article, information about the conflict of interest and the source of funding should be disclosed.
Title
The title of the article should be succinct and concise, and fully reflect the essence of the material presented. The use of invented names of drugs is not allowed in the article title. The study design should be added to the title of the original articles.
Information about the authors
The names and initials of the authors of the article should be indicated in two languages.
The names of the institutions are specified in full, including the postal address.
If more than one institution took part in the article, it is necessary to make footnotes 1, 2, 3 .., according to the authors' belonging to these institutions.
Information about the corresponding author must contain: full name, academic degree, position, place of work (including the postal address and the post code of the institution), contacts (e-mail, phone). The ORCID/Scopus ID of all authors are also required. It is strongly recommended (in the interests of the authors) to indicate the individual code of the researcher, which can be obtained by registering with the ORCID system (https://orcid.org/). This will allow to avoid possible citation losses.
Example of the corresponding author’s information (in two languages):
Автор для связи: М.Б. Анциферов, д.м.н., проф., главный врач ГБУЗ «Эндокринологический диспансер» Департамента здравоохранения г. Москвы, Москва, Россия; e-mail: antsiferov@rambler.ru; ORCID: http://orcid.com/0000-0002-9944-2997; eLibrary SPIN: 1035–4773
Адрес: 119034, Россия, Москва, ул. Пречистенка, 37
Corresponding author: Mikhail B. Antsiferov, MD, Professor, Physician of the Moscow Healthcare Department, Moscow, Russia; e-mail: antsiferov@rambler.ru; ORCID: http://orcid.com/0000-0002-9944-2997; eLibrary SPIN: 1035–4773
Address: 37, Prechistenka Street, Moscow 119034, Russian Federation
Abstract
The abstract should be no more than is 250–500 words. For all articles except literature reviews and clinical guidelines, the abstract should be structured. For original articles, it should include background, objective, methods, results, conclusion; for an article with a clinical example: background, description of a clinical case, conclusion).
Also, abstract should include "key words" (from 5 to 15 words), contributing to article indexing in data retrieval systems. For choosing keywords, we recommend using the MeSH keywords dictionary (https://www.nlm.nih.gov/mesh/meshhome.html).
Text
General requirements
The approximate size of the original article should be about 7–8 pages, for brief communication and notes from the practice - 3-4 pages. Reviews should not exceed 12 pages. For various types of articles, there are corresponding templates for design and structuring presented on the publisher’s website in Russian and English languages.
Templates for execution of articles: a clinical example, a review, the original article.
Articles describing clinical examples must contain the following sections: background, description of the clinical case, discussion, conclusion. Original articles should include sections: background, objective, methods, results, discussion, conclusion or conclusions.
For writing original articles we recommend using the CONSORT standards; for systematic reviews and meta-analyses - PRISMA standards. It is also recommended to use the study guide Popova N.G., Koptyaeva N.N. (2014) Akademicheskoe pis’mo: stat’i IMRAD [Academic Writing: IMRAD papers]. Study guide for postgraduates and research fellows of natural-science specialities. Yekaterinburg: Institute of Philosophy and Law Publ., 160 p. (In Russ.).
Statistical analysis: The statistical methods in the study should be described in the section “Statistical Analysis” at the end of the section “Methods”. Their description should be as detailed as necessary to assess their adequacy and confirm the results obtained by knowledgeable readers, provided access to relevant data. The description and presentation of the results of statistical analysis should be performed in accordance with the "Statistical Analysis and Methods in Published Literature" (SAMPL) Guidelines.
Articles should use the SI system.
The use of abbreviations in the text of the article is not allowed, except for generally accepted abbreviations of chemical and mathematical quantities, terms. All abbreviations (with the exception of units of measurement) are used only after the first mention of the full name of the term. Special terms should be given in Russian translation, and author should use only words generally accepted in scientific literature. The use of foreign words in the Russian version in the "own" transcription is absolutely prohibited.
In all publications, only international nonproprietary names (INN) of medicinal products should be used. The exceptions include: combined drugs, multicomponent drugs, herbal medicinal products or products of animal origin.
The citations given in the article should be carefully verified; the reference should specify the source, its name, year, issue, page, DOI.
Before being sent to the editors, the article should be edited and verified by the author. The presentation should be clear, without long introductions and repetitions.
The article should not exceed 3/4 of the author's sheet (30 thousand characters).
Tables
Each table should have a title and an order number according to its reference in the text. References to tables in text should be given in italics parenthetically (Table 1). Columns in the table should have short headings. All explanations, including interpretation of abbreviations, should be placed in footnotes. If the table is taken from the Internet or a PDF file, it is necessary to type it manually (tables in the form of photos are not accepted). Borrowed tables should have source reference
Tables should be built visually and correspond to the contents of the graph. Columns in the table should have short headers. All figures, totals and percentages in the tables should be carefully verified by the author and correspond to the figures in the text. The units of measurement must be specified to all indicators in Russian.
Illustrations
The figure file format should be tiff or jpeg, file extension - from 300 dpi, size - from 1 MB. The numbering of the figures should be given in Arabic numerals in parentheses according to the order in which they are mentioned in the text. The figure caption should be located immediately after the drawing. The figure caption should be consisted of the title and “legend” (explanations of parts of the figure, symbols, arrows and its other details in Russian). Graphs and charts should not contain text label overload.
Figures in the form of graphs, diagrams must be supplemented with digital data in the form of Excel spreadsheet, because in accordance with the technology of preparing the layout of the journal for printing, such figures are painted again by the artist of the publishing house, and not simply copied.
When using borrowed figures, citation is required; if figure is borrowed from a foreign publication, Russian translation of all designations in the figure and an indication ... is adapted to [source number cited in the reference list] are required.
Reference list
Correct indication of the sources used in the reference lists ensures that the cited publication will be taken into account when evaluating the scientific activities of its authors and organizations where they work.
References attached to the article should include the fundamental or most relevant works of domestic and foreign authors over the last 5-7 years. The only exceptions are rare high-informative works. The original articles should cite no more than 30 sources, the reviews - no more than 50 sourses.
Sources are listed STRICTLY IN THE ORDER OF Citing (references to them in the text), i.e. 1, 2, 3, etc., NOT in alphabetical order, and are indicated in Arabic numerals in square brackets. In the references list, each source comes from a new line with its own serial number. References to works that are not in the list of references and vice versa are not allowed: all documents to which the authors refer in the text should be included in the reference list; references to works unpublished in press and official electronic publications, as well as to works from way back are not allowed.
The reference list is made according to the rules of drawing up references (bibliography) for authors taking into account the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” by the International Committee of Medical Journal Editors.
In order to increase the citation of authors, the journal is transliterated for Russian-language sources (the authors and the name of the journal are transliterated using encodings, and the title of the article/book is translated into English). For transliteration, one of the BSI online services is used. The names of foreign authors are given in the original transcription.
As required by international databases, at the end of the literary reference, English-language and Russian-language (where available), it is necessary to affix a digital object identifier - the DOI index - in order to increase the relevance and citation of scientific works.
Examples of reference list:
Books
- Постнов Ю.В., Орлов С.Н. Первичная артериальная гипертензия как патология клеточных мембран. М., 1987. [Postnov Yu.V., Orlov S.N. Primary hypertension as a pathology of cell membranes. Moscow, 1987. (In Russ.)].
- Levey A.S. Clinical evaluation of renal function. In Greenberg A. (ed.) Primer on kidney disease. San Diego (California): Academic Press, 1998. P. 20–27.
Journals
- Вербовая Н.И., Капралова И.Ю., Вербовой А.Ф. Содержание остеопротегерина и адипокинов при гипотиреозе у женщин. Врач. 2014;8:66–8. [Verbovaya N.I., Kapralova I.Yu., Verbovoj A.F. The content of osteoproteins and adipokines in hypothyroidism in women. Vrach. 2014; 8: 66–8. (In Russ.)].
- Peralta C.A., Shlipak, M.G., Wasser-Fyr, C., et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007; 50: 474–80. DOI: 10.1161 / HYPERTENSIONAHA.107.088088
References should follow the format recommended by the National Information Standards Organization (NISO) approved by the National Library of Medicine (NLM) for databases (Library's MEDLINE / PubMed database) NLM: http: //www.nlm. nih.gov/citingmedicine.
The names of Russian publications must be written completely without abbreviations to ensure citation in international databases.
Journal title abbreviations should be consistent with Index Medicus.
References to thesis research, abstracts and autoabstracts are not recognized by the international community, therefore they should be given only in exceptional cases.
The author is solely responsible for the accuracy of the references list.
If a literary reference has obvious inaccuracies or is not mentioned in the text of the article, the editors reserve the right to exclude it from the reference list.
Special requirements
- When writing an article, authors should follow the “Guidelines for Conducting, Describing, Editing and Publishing Scientific Research Results in Medical Journals” by the International Committee of Medical Journal Editors (ICMJE). In Russian, they are presented here.
The author must sign the article. A collective article must be signed by all authors indicating the role of each.
For example:
- Concept and design of study - I.I. Ivanov, P.P. Petrov
- Collection and processing of material – S.S. Sidorov
- Statistical data processing – S.S. Sidorov
- Writing text – P.P. Petrov
- Editing - I.I. Ivanov
By putting his signature under the article, the author thereby transfers to the editorial board the right to publish it, guarantees its originality and certifies that neither the article nor the figures to it have been published before or sent to other publications for release. When determining authorship, it is recommended to follow the ICJME criteria.
Acknowledgments
The authors can thank the persons and organizations that contributed to the preparation of the article.
Information on sources of funding
It is necessary to indicate the source of funding for the study, the preparation of a review or lecture (the name of the planned study preformed for national reasons, the grant number and the name of the foundation, a commercial or state organization, etc.). Specification of the amount of funding is not required.
Conflict of interest
The presence or absence of a potential conflict of interest (for example, competing interests that, in the opinion of the author, may have a direct or indirect influence on the publication process) (see ICJME recommendations) should be declared.
Examination and publication of manuscripts
The decision to publish the materials sent to the journal is made by the editorial board and scientific editors of the «Farmateka» journal.
When reviewing received manuscripts, the editors of the journal are guided by the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (Intern. Committee of medical journal editors. Uniform requirements for manuscripts submitted to biomedical journals. Ann Intern Med. 1997; 126: 36–47), EASE principles and the Singapore Statement on Research Integrity. (https://wcrif.org/).
The editors reserve the right to shorten and edit articles. Articles previously published or sent to another journal are not accepted for publication. Articles that do not meet these requirements may be returned to authors without examination.
- The author is solely responsible for any plagiarism of text, figures, etc. The editorial board, when receiving an article, carries out an inspection of the material using the Anti-plagiarism system. In case of detection of multiple borrowings, the editors act in accordance with the COPE rules.
- The author is responsible for complying with national and local laws when conducting research involving people and animals (for example, the WMA Declaration of Helsinki; NCDs policy on animal research; EU directive on animal testing). The author must obtain informed consent to the publication from the person(s) who participated in the study, and to maintain confidentiality.
The fee for the publication of manuscripts is not charged.
The editorial staff also helps in the preparation and publication of books and manuals.
For any questions, please contact the editorial office: tel. 8(909)150-02-82; e-mail: pharmateca@yandex.ru
Copyright Notice
ICMJE (International Committee of Medical Journal editors) recommends authorship to be based on the following 4 criteria:
- Significant contribution to the study concept and design, or the acquisition and analysis of data, or their interpretation
- Writing the first version of the article or substantial revision of its important intellectual content
- Final approval of the publication version
4. Consent to be responsible for all aspects of the work and ensure appropriate consideration and resolution of issues related to the accuracy and integrity of all parts of the work. In addition to responsibility for the part of the work that was done by the author, the author should be able to indicate co-author who is responsible for the other parts of the work. Furthermore, authors should be assured of the good faith contribution of their co-authors. All persons designated as authors must meet all four criteria for authorship, and all persons who meet the criteria for authorship must be listed in the list of authors.
Persons who do not meet all four criteria for authorship should be listed in the “Acknowledgements” section. These criteria for authorship are designed to ensure that the status of authorship is given to those who are trustworthy and can take responsibility for the published work. These criteria should not serve as a means of excluding colleagues who meet the remaining criteria, by depriving them of the ability to meet criteria 2 or 3. Therefore, all persons meeting the first criterion should be able to participate in the processing, writing of the first version of the manuscript and its final approval for publication. The persons conducting the work are responsible for identifying those who meet these criteria and, ideally, should do it during the planning of the work, and, as the work proceeds, make the necessary changes. Authors, but not the magazine in which the work is submitted, should jointly establish that all persons listed in the list of authors meet all four criteria. The magazine editors’ tasks do not include determining who meets or does not meet the requirements for authorship, or the resolution of conflicts related to authorship. If it is not possible to reach an agreement on who can be qualified as an author, the study site(s), but not the magazine editor, should be asked for resolution of the disputed issue. If authors are asked to remove or add an author after submitting or publishing a manuscript, magazine editors should receive appropriate explanations and a signed statement of consent from all the authors listed for the requested change, as well as from the author whose name should be removed or added. The corresponding author is primarily responsible for communicating with the magazine in the process of submitting, reviewing and publishing the manuscript, and he usually ensures that all administrative requirements of the magazine are met correctly, for example, specifying the authors' details, obtaining approval from the ethics committee and clinical registration documents, and collecting forms and conflict of interest statements. However, these responsibilities may also be assigned to one or more of the other co-authors. The corresponding author must be available throughout the process of submitting and reviewing the manuscript in order to promptly answer editorial questions, as well as after publication, to respond to criticism of the work and provide any data and additional information upon editorial request if there are any questions about the article after its publication. Although the corresponding author is primarily responsible for correspondence with the magazine, ICMJE recommends editors to send copies of all correspondence to all the authors listed. If the study is conducted by a large group, ideally, this group should decide who will be the author before starting work and confirm this decision before submitting the manuscript to the magazine. All members of the group included in the list of authors must meet all four criteria for authorship, including the approval of the final version of the manuscript, accept public responsibility for this work and have complete confidence in the accuracy and integrity of the work of the other members of the group of authors. They must also personally complete the conflict of interest forms. Some large groups of authors denote authorship by the name of the group, with or without indication of individuals. When submitting a manuscript on behalf of a group of authors, the corresponding author must indicate the name of the group, if any, and clearly identify the members of the group who can be entrusted with the reliance and responsibility for this work as authors. If the byline of article indicates who is directly responsible for the manuscript, and MEDLINE will list all authors indicted in byline. If the byline contains the group name, MEDLINE will list the individual members of the group who are authors, as well as participants, who are sometimes called as non-authors contributors, if available the note to the byline that clearly indicates that the list of individual participants is given in article elsewhere, and which of these participants is the author or another contributor.
Other participants of the work who do not meet all 4 criteria of authorship mentioned above should not be indicated as authors, but they should be thanked. Examples of activities that alone (without any other contribution to the work) cannot be considered a sufficient basis for authorship include fundraising, general management of a research group or general administrative support, writing assistance, technical editing, linguistic editing, and proofreading. Individuals whose contribution does not qualify as authorship can be thanked individually or collectively as a group under one heading (for example, “Clinical Researchers” or “Research Participants”), and their specific contribution should be indicated (for example, “participated as a scientific consultant ","critically evaluated the study plan", "collected data", "included patients in the study and participated in their treatment", "participated in the writing or technical editing of the manuscript"). Since the inclusion in the “Acknowledgements” section may imply confirmation of the data and the conclusion of the study by persons who will be thanked, editors are encouraged to ask the corresponding author to obtain written permission to be mentioned in “Acknowledgements” from all persons who will be thanked.
Privacy Statement
Authors and Reviewers
Manuscripts should be reviewed with due respect for authors' confidentiality. In submitting their manuscripts for review, authors entrust editors with the results of their scientific work and creative effort, on which their reputation and career may depend. Authors' rights may be violated by disclosure of the confidential details of the review of their manuscript.In addition, the editor should respect reviewer rights to confidentiality. It may need to be breached only in order to prevent fraud and deception.
Editors must not disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or outcome of the reviewing process) to anyone other than the authors and reviewers. This includes requests to use the materials for legal proceedings.
Editors should notify their reviewers that manuscripts sent for review are confidential communications and the private property of the authors. Therefore, reviewers and members of the editorial staff must respect the authors' rights by not publicly discussing the authors' work before the manuscript is published. Reviewers must be prohibited from making copies of the manuscript and sharing it with any other party, except with the permission of the editor.
Reviewer comments should not be published or otherwise made public without permission of reviewer, authors and the editor.
The Journal policy is to blind authors to reviewer identity. If reviewer comments sent to authors are not signed, the reviewer identity must not be revealed to authors or anyone else without the reviewers’ expressed written permission.
Peer reviewers’ comments should not be published without permission of the reviewer and authors. At the same time, reviewers’ comments should be sent to other persons reviewing the same manuscript, which helps reviewers learn from the review process. Reviewers also may be notified of the editor's decision to accept or reject a manuscript.
Patients and Study Participants
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.
Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.
Patient consent should be written and archived with the Journal, the authors, or both, as dictated by local regulations or laws. Applicable laws vary from locale to locale, and Journals should establish their own policies with legal guidance.
In order to better protect patient identity, written consent of patients can be archived by the authors. In this case, the authors should provide the Journal with a written statement that attests that they have received and archived written patient consent.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. The requirement for informed consent should be included in the Journal’s instructions for authors. When informed consent has been obtained it should be indicated in the published article.
